Table 3.
Authorship and topics discussed regarding the meningococcal B vaccine and tone of the message
| Benefits |
||||
| Type of authorship, % (n) |
Discussed (n = 53) |
Not discussed (n = 24) |
OR (95%CI) |
p |
| Healthcare professionals | 24.5 (13) | 8.3 (2) | 3.58 (0.74-17.30) | 0.126 |
| Other |
75.5 (40) |
91.7 (22) |
1 |
|
| Effectiveness |
||||
| Type of authorship, % (n) |
Discussed (n =19) |
Not discussed (n = 58) |
OR (95%CI) |
p |
| Healthcare professionals | 42.1 (8) | 12.1 (7) | 5.29 (1.59-17.69) | 0.008 |
| Other |
57.9 (11) |
87.9 (51) |
1 |
|
| Adverse effects |
||||
| Type of authorship, % (n) |
Discussed (n = 16) |
Not discussed (n =61) |
OR (95%CI) |
p |
| Healthcare professionals | 50.0 (8) | 11.5 (7) | 7.71 (2.19-27.12) | 0.002 |
| Other |
50.0 (8) |
88.5 (54) |
1 |
|
| Cost |
||||
| Type of authorship, % (n) |
Discussed (n = 20) |
Not discussed (n = 57) |
OR (95%CI) |
p |
| Healthcare professionals | 15.0 (3) | 21.1 (12) | 0.66 (0.17-2.64) | 0.747 |
| Other |
85.0 (17) |
78.9 (45) |
1 |
|
| Route of administration |
||||
| Type of authorship, % (n) |
Discussed (n = 12) |
Not discussed (n = 65) |
OR (95%CI) |
p |
| Healthcare professionals | 16.7 (2) | 20.0 (13) | 0.80 (0.16-4.11) | 1.000 |
| Other |
83.3 (10) |
80.0 (52) |
1 |
|
| Description of the dosage |
||||
| Type of authorship, % (n) |
Discussed (n = 17) |
Not discussed (n = 60) |
OR (95%CI) |
p |
| Healthcare professionals | 47.1 (8) | 11.7 (7) | 6.73 (1.96-23.17) | 0.003 |
| Other |
52.9 (9) |
88.3 (53) |
1 |
|
| Alert that a preventable disease may be contracted |
||||
| Type of authorship, % (n) |
Discussed (n = 62) |
Not discussed (n = 15) |
OR (95%CI) |
p |
| Healthcare professionals | 22.6 (14) | 6.7 (1) | 4.08 (0.49-33.83) | 0.277 |
| Other |
77.4 (48) |
93.3 (14) |
1 |
|
| OR (95%CI): Odds Ratio (95% confidence interval) | ||||
| Recommendation in cases of epidemic outbreak |
||||
| Type of authorship, % (n) |
Discussed (n = 22) |
Not discussed (n = 55) |
OR (95%CI) |
p |
| Healthcare professionals | 18.2 (4) | 20.0 (11) | 0.89 (0.25-3.16) | 1.000 |
| Other |
81.8 (18) |
80.0 (44) |
1 |
|
| Recommendation in cases of properdin deficiency |
||||
| Type of authorship, % (n) |
Discussed (n = 1) |
Not discussed (n = 76) |
OR (95%CI) |
p |
| Healthcare professionals | 100 (1) | 18.4 (14) | - | 0.195 |
| Other |
0 (0) |
81.6 (62) |
|
|
| Recommendation in cases of treatment with eculizumab |
||||
| Type of authorship, % (n) |
Discussed (n = 1) |
Not discussed (n = 76) |
OR (95%CI) |
p |
| Healthcare professionals | 100 (1) | 18.4 (14) | - | 0.195 |
| Other |
0 (0) |
81.6 (62) |
|
|
| Recommendation in cases of asplenic patients |
||||
| Type of authorship, % (n) |
Discussed (n = 2) |
Not discussed (n = 75) |
OR (95%CI) |
p |
| Healthcare professionals | 100 (2) | 17.3 (13) | - | 0.036 |
| Other |
0 (0) |
82.7 (62) |
|
|
| Recommendation in cases of terminal complement pathway deficiencies |
||||
| Type of authorship, % (n) |
Discussed (n = 3) |
Not discussed (n = 74) |
OR (95%CI) |
p |
| Healthcare professionals | 100 (3) | 16.2 (12) | - | 0.006 |
| Other |
0 (0) |
83.8 (62) |
|
|
| Recommendation for laboratory staff |
||||
| Type of authorship, % (n) |
Discussed (n = 3) |
Not discussed (n = 74) |
OR (95%CI) |
p |
| Healthcare professionals | 66.7 (2) | 17.6 (13) | 9.39 (0.79-111.39) | 0.095 |
| Other |
33.3 (1) |
82.4(61) |
1 |
|
| OR (95%CI): Odds Ratio (95% confidence interval) | ||||
| Recommendation in children |
||||
| Type of authorship, % (n) |
Discussed (n = 14) |
Not discussed (n = 63) |
OR (95%CI) |
p |
| Healthcare professionals | 14.3 (2) | 20.6 (13) | 0.64 (0.13-3.23) | 0.725 |
| Other | 85.7 (12) | 79.4 (50) | 1 | |
| Recommendation in young adults |
||||
| Type of authorship, % (n) |
Discussed (n = 4) |
Not discussed (n = 73) |
OR (95%CI) |
p |
| Healthcare professionals | 25.0 (1) | 19.2 (14) | 1.41 (0.14-14.54) | 1.000 |
| Other |
75.0 (3) |
80.8 (59) |
1 |
|
| Recommendation in teenagers |
||||
| Type of authorship, % (n) |
Discussed (n = 9) |
Not discussed (n = 68) |
OR (95%CI) |
p |
| Healthcare professionals | 33.3 (3) | 17.6 (12) | 2.33 (0.51-10.67) | 0.366 |
| Other |
66.7 (6) |
82.4 (56) |
1 |
|
| Tone of the message |
||||
| Type of authorship, % (n) |
Positive (n = 57) |
Others (n = 20) |
OR (95%CI) |
p |
| Healthcare professionals | 26.3 (15) | 0 (0) | - | 0.008 |
| Other | 73.7 (42) | 100 (20) | ||
OR (95% CI): odds ratio (95% confidence interval).